Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDImmucell Corp. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 1 | $0.05 | $0.05 | $0.05 |
| Q2 2026 | 1 | -$0.08 | -$0.08 | -$0.08 |
| Q3 2026 | 1 | -$0.06 | -$0.06 | -$0.06 |
| Q4 2026 | 1 | -$0.01 | -$0.01 | -$0.01 |
| Q1 2027 | 1 | -$0.08 | -$0.08 | -$0.08 |
| Q2 2027 | 1 | -$0.06 | -$0.06 | -$0.06 |
| Q3 2027 | 1 | -$0.01 | -$0.01 | -$0.01 |
Immucell Corp. Earnings Date And Information
Immucell Corp. last posted its earnings results on Wednesday, March 4th, 2026. The company reported $-0.31 earnings per share for the quarter, missing analysts' consensus estimates of $0.05 by $0.36. The company had revenue of 7.63 M for the quarter and had revenue of 27.64 M for the year. Immucell Corp. has generated $0 earnings per share over the last year ($-0.12 diluted earnings per share) and currently has a price-to-earnings ratio of -72.72. Immucell Corp. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Immucell Corp. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 03/30/2026 | Q4 2025 | N/A | -$0.31 | N/A | $5.40 M | $7.63 M |
| 11/13/2025 | Q3 2025 | N/A | -$0.02 | N/A | $3.00 M | $5.51 M |
| 08/14/2025 | Q2 2025 | N/A | $0.06 | N/A | $3.00 M | $6.44 M |
| 05/14/2025 | Q1 2025 | N/A | $0.16 | N/A | $3.00 M | $8.07 M |
| 03/28/2025 | Q4 2024 | N/A | $0.06 | N/A | N/A | $7.75 M |
| 11/13/2024 | Q3 2024 | N/A | -$0.09 | N/A | $5.40 M | $6.01 M |
| 08/13/2024 | Q2 2024 | N/A | -$0.20 | N/A | $3.59 M | $5.47 M |
| 05/14/2024 | Q1 2024 | N/A | -$0.06 | N/A | $3.26 M | $7.26 M |
| 04/01/2024 | Q4 2023 | N/A | -$0.15 | N/A | N/A | $5.10 M |
| 11/13/2023 | Q3 2023 | N/A | -$0.12 | N/A | N/A | $5.40 M |
| 08/10/2023 | Q2 2023 | N/A | -$0.18 | N/A | N/A | $3.53 M |
| 05/11/2023 | Q1 2023 | N/A | -$0.30 | N/A | N/A | $3.45 M |
| 03/29/2023 | Q4 2022 | N/A | -$0.22 | N/A | N/A | $3.91 M |
| 11/21/2022 | Q3 2022 | N/A | -$0.08 | N/A | N/A | $4.80 M |
| 08/11/2022 | Q2 2022 | N/A | -$0.09 | N/A | N/A | $3.86 M |
| 05/12/2022 | Q1 2022 | -$0.10 | $0.09 | 0.19 | N/A | $6.00 M |
| 03/30/2022 | Q4 2021 | N/A | $0.01 | N/A | N/A | $5.44 M |
| 11/15/2021 | Q3 2021 | -$0.06 | $0.02 | 0.08 | N/A | $5.15 M |
| 08/12/2021 | Q2 2021 | -$0.08 | $0.02 | 0.1 | N/A | $4.54 M |
| 05/13/2021 | Q1 2021 | $0.05 | -$0.06 | -0.11 | N/A | $4.11 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Immucell Corp. Earnings: FAQ's
The conference call for Immucell Corp.'s latest earnings report can be listened to online.
The conference call transcript for Immucell Corp.'s latest earnings report can be read online.
Immucell Corp. (:ICCC) has a recorded annual revenue of $27.64 M.
Immucell Corp. (:ICCC) has a recorded net income of $-1,040,000.Immucell Corp. has generated $-0.12 earnings per share over the last four quarters.
Immucell Corp. (:ICCC) has a price-to-earnings ratio of -72.72 and price/earnings-to-growth ratio is 0.12.